Insider Richard Barry Just Doubled Down on Cassava (SAVA) Stock
InvestorPlaceInvestorPlace – Stock Market News, Stock Advice & Trading Tips
Cassava is still enrolling patients in its Phase 3 study of the drug, which has a different target than Biogen’s Leqembi.
The post Insider Richard Barry Just Doubled Down on Cassava (SA…